List of works - Thai Huu Ho

A Multidisciplinary Biospecimen Bank of Renal Cell Carcinomas Compatible with Discovery Platforms at Mayo Clinic, Scottsdale, Arizona

scientific article

A Study of Combination Bicalutamide and Raloxifene for Patients With Castration-Resistant Prostate Cancer.

scientific article published on 8 September 2016

Androgen Receptor Variant AR-V9 Is Coexpressed with AR-V7 in Prostate Cancer Metastases and Predicts Abiraterone Resistance.

scientific article published on 4 May 2017

Assessing the clinical use of clear cell renal cell carcinoma molecular subtypes identified by RNA expression analysis.

scientific article published on 28 August 2014

Assessment of pazopanib-related hypertension, cardiac dysfunction and identification of clinical risk factors for their development.

scientific article published on 30 June 2017

Axitinib in the Treatment of Metastatic Renal Cell Carcinoma ⬇️

scientific article published on November 1, 2011

BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor.

scientific article

Behavior of blood plasma glycan features in bladder cancer

scientific article published on 24 July 2018

Clear Cell Renal Cell Carcinoma Subtypes Identified by BAP1 and PBRM1 Expression.

scientific article published on 20 August 2015

Clear Cell Type A and B Molecular Subtypes in Metastatic Clear Cell Renal Cell Carcinoma: Tumor Heterogeneity and Aggressiveness.

scientific article published on 26 November 2016

Clinical Implementation of Integrated Genomic Profiling in Patients with Advanced Cancers

scientific article

Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy

scientific article

Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients

article

Comprehensive Characterization of Cancer Driver Genes and Mutations

article

Comprehensive Genomic Analysis of Metastatic Mucinous Urethral Adenocarcinoma Guides Precision Oncology Treatment: Targetable EGFR Amplification Leading to Successful Treatment With Erlotinib

scientific article published on 01 December 2016

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma

scientific article published on 4 November 2015

Concordance of PD-1 and PD-L1 (B7-H1) in paired primary and metastatic clear cell renal cell carcinoma

scientific article published on 12 December 2019

Correlation Between Molecular Subclassifications of Clear Cell Renal Cell Carcinoma and Targeted Therapy Response.

scientific article

Correlation of PD-L1 tumor expression and treatment outcomes in patients with renal cell carcinoma receiving sunitinib or pazopanib: results from COMPARZ, a randomized controlled trial

scientific article published on 23 December 2014

DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas.

scientific article published on 02 June 2016

Detection of tumor-associated cells in cryopreserved peripheral blood mononuclear cell samples for retrospective analysis.

scientific article published on 02 July 2016

Distinct and overlapping control of 5-methylcytosine and 5-hydroxymethylcytosine by the TET proteins in human cancer cells

scientific article

Dual Chromatin and Cytoskeletal Remodeling by SETD2.

scientific article published on August 2016

Dynamic reprogramming of DNA methylation in SETD2-deregulated renal cell carcinoma.

scientific article published on 5 December 2015

Ebselen inhibits QSOX1 enzymatic activity and suppresses invasion of pancreatic and renal cancer cell lines

scientific article published on June 2015

Factors Associated With Survival Following Radium-223 Treatment for Metastatic Castration-resistant Prostate Cancer.

scientific article published on 26 April 2017

Genetic kidney cancer syndromes

scientific article published on September 2014

Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma

scientific article published on 4 January 2018

Hypoxia-induced SUMOylation of E3 ligase HAF determines specific activation of HIF2 in clear-cell renal cell carcinoma.

scientific article

In silico DNA methylation analysis identifies potential prognostic biomarkers in type 2 papillary renal cell carcinoma

scientific article published on 30 July 2019

Inhibition of Intracellular Lipolysis Promotes Cancer Cell Adaptation to Hypoxia

Inhibition of intracellular lipolysis promotes human cancer cell adaptation to hypoxia

scientific article published on 19 December 2017

Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma

scientific article

Loss of PBRM1 and BAP1 expression is less common in non-clear cell renal cell carcinoma than in clear cell renal cell carcinoma

scientific article

Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death

scientific article

Macrophage HIF-1α is an independent prognostic indicator in kidney cancer ⬇️

scientific article published on 25 June 2020

MicroRNA Expression in Clear Cell Renal Cell Carcinoma Cell Lines and Tumor Biopsies: Potential Therapeutic Targets

scientific article published on 17 May 2022

Molecular Inhibitor of QSOX1 Suppresses Tumor Growth In Vivo

scientific article published on 01 October 2019

Molecular characterization of sarcomatoid clear cell renal cell carcinoma unveils new candidate oncogenic drivers

scientific article published on 20 January 2020

Multicenter Validation of Enhancer of Zeste Homolog 2 Expression as an Independent Prognostic Marker in Localized Clear Cell Renal Cell Carcinoma

scientific article published on 4 October 2017

Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma

scientific article published on 2 March 2016

Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma

scientific article published on February 2016

PD-1 and PD-L1 Expression in Renal Cell Carcinoma with Sarcomatoid Differentiation

scientific article

Pazopanib for renal cell carcinoma leads to elevated mean arterial pressures in a murine model.

scientific article published on 27 November 2017

Perioperative complications after neoadjuvant chemotherapy and radical cystectomy for bladder cancer

scientific article

Predictors of incipient dysfunction of all cardiac chambers after treatment of metastatic renal cell carcinoma by tyrosine kinase inhibitors.

scientific article

Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti-PD-1 Therapies in Metastatic Melanoma

scientific article published on 18 July 2018

Stage Dependence, Cell-Origin Independence, and Prognostic Capacity of Serum Glycan Fucosylation, β1-4 Branching, β1-6 Branching, and α2-6 Sialylation in Cancer.

scientific article published on 12 November 2017

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

scientific article published in April 2018

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

article

The Impact of Pazopanib on the Cardiovascular System.

scientific article published in January 2018

The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas

scientific article

The impact of FGFR1 and FRS2α expression on sorafenib treatment in metastatic renal cell carcinoma

scientific article published on 18 April 2015

The mechanism of inhibition of Ran-dependent nuclear transport by cellular ATP depletion.

scientific article

Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy.

scientific article

Validation of Gene Expression Signatures to Identify Low-risk Clear-cell Renal Cell Carcinoma Patients at Higher Risk for Disease-related Death.

scientific article published on 2 April 2016

Variation in chromatin accessibility in human kidney cancer links H3K36 methyltransferase loss with widespread RNA processing defects

scientific article published on 24 October 2013

Whole-Exome Sequencing in Two Extreme Phenotypes of Response to VEGF-Targeted Therapies in Patients With Metastatic Clear Cell Renal Cell Carcinoma

scientific article published on July 2016

List of works by Thai Huu Ho

A Multidisciplinary Biospecimen Bank of Renal Cell Carcinomas Compatible with Discovery Platforms at Mayo Clinic, Scottsdale, Arizona

A Study of Combination Bicalutamide and Raloxifene for Patients With Castration-Resistant Prostate Cancer.

Androgen Receptor Variant AR-V9 Is Coexpressed with AR-V7 in Prostate Cancer Metastases and Predicts Abiraterone Resistance.

Assessing the clinical use of clear cell renal cell carcinoma molecular subtypes identified by RNA expression analysis.

Assessment of pazopanib-related hypertension, cardiac dysfunction and identification of clinical risk factors for their development.

Axitinib in the Treatment of Metastatic Renal Cell Carcinoma ⬇️

BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor.

Behavior of blood plasma glycan features in bladder cancer

Clear Cell Renal Cell Carcinoma Subtypes Identified by BAP1 and PBRM1 Expression.

Clear Cell Type A and B Molecular Subtypes in Metastatic Clear Cell Renal Cell Carcinoma: Tumor Heterogeneity and Aggressiveness.

Clinical Implementation of Integrated Genomic Profiling in Patients with Advanced Cancers

Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy

Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients

Comprehensive Characterization of Cancer Driver Genes and Mutations

Comprehensive Genomic Analysis of Metastatic Mucinous Urethral Adenocarcinoma Guides Precision Oncology Treatment: Targetable EGFR Amplification Leading to Successful Treatment With Erlotinib

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma

Concordance of PD-1 and PD-L1 (B7-H1) in paired primary and metastatic clear cell renal cell carcinoma

Correlation Between Molecular Subclassifications of Clear Cell Renal Cell Carcinoma and Targeted Therapy Response.

Correlation of PD-L1 tumor expression and treatment outcomes in patients with renal cell carcinoma receiving sunitinib or pazopanib: results from COMPARZ, a randomized controlled trial

DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas.

Detection of tumor-associated cells in cryopreserved peripheral blood mononuclear cell samples for retrospective analysis.

Distinct and overlapping control of 5-methylcytosine and 5-hydroxymethylcytosine by the TET proteins in human cancer cells

Dual Chromatin and Cytoskeletal Remodeling by SETD2.

Dynamic reprogramming of DNA methylation in SETD2-deregulated renal cell carcinoma.

Ebselen inhibits QSOX1 enzymatic activity and suppresses invasion of pancreatic and renal cancer cell lines

Factors Associated With Survival Following Radium-223 Treatment for Metastatic Castration-resistant Prostate Cancer.

Genetic kidney cancer syndromes

Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma

Hypoxia-induced SUMOylation of E3 ligase HAF determines specific activation of HIF2 in clear-cell renal cell carcinoma.

In silico DNA methylation analysis identifies potential prognostic biomarkers in type 2 papillary renal cell carcinoma

Inhibition of Intracellular Lipolysis Promotes Cancer Cell Adaptation to Hypoxia

Inhibition of intracellular lipolysis promotes human cancer cell adaptation to hypoxia

Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma

Loss of PBRM1 and BAP1 expression is less common in non-clear cell renal cell carcinoma than in clear cell renal cell carcinoma

Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death

Macrophage HIF-1α is an independent prognostic indicator in kidney cancer ⬇️

MicroRNA Expression in Clear Cell Renal Cell Carcinoma Cell Lines and Tumor Biopsies: Potential Therapeutic Targets

Molecular Inhibitor of QSOX1 Suppresses Tumor Growth In Vivo

Molecular characterization of sarcomatoid clear cell renal cell carcinoma unveils new candidate oncogenic drivers

Multicenter Validation of Enhancer of Zeste Homolog 2 Expression as an Independent Prognostic Marker in Localized Clear Cell Renal Cell Carcinoma

Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma

Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma

PD-1 and PD-L1 Expression in Renal Cell Carcinoma with Sarcomatoid Differentiation

Pazopanib for renal cell carcinoma leads to elevated mean arterial pressures in a murine model.

Perioperative complications after neoadjuvant chemotherapy and radical cystectomy for bladder cancer

Predictors of incipient dysfunction of all cardiac chambers after treatment of metastatic renal cell carcinoma by tyrosine kinase inhibitors.

Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti-PD-1 Therapies in Metastatic Melanoma

Stage Dependence, Cell-Origin Independence, and Prognostic Capacity of Serum Glycan Fucosylation, β1-4 Branching, β1-6 Branching, and α2-6 Sialylation in Cancer.

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

The Impact of Pazopanib on the Cardiovascular System.

The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas

The impact of FGFR1 and FRS2α expression on sorafenib treatment in metastatic renal cell carcinoma

The mechanism of inhibition of Ran-dependent nuclear transport by cellular ATP depletion.

Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy.

Validation of Gene Expression Signatures to Identify Low-risk Clear-cell Renal Cell Carcinoma Patients at Higher Risk for Disease-related Death.

Variation in chromatin accessibility in human kidney cancer links H3K36 methyltransferase loss with widespread RNA processing defects

Whole-Exome Sequencing in Two Extreme Phenotypes of Response to VEGF-Targeted Therapies in Patients With Metastatic Clear Cell Renal Cell Carcinoma